We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi and Regeneron Give Up on Kevzara for COVID-19 After Phase 3 Flop
Sanofi and Regeneron Give Up on Kevzara for COVID-19 After Phase 3 Flop
Sanofi and Regeneron Pharmaceuticals said they have no plans to conduct further trials of their rheumatoid arthritis drug Kevzara for COVID-19 after it failed in a late-stage study.